Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial
Cardiovascular risk reduction : Wegovy is covered by some plans, including Medicare Part D, when prescribed for cardiovascular risk reduction in patients with established heart disease and BMI 27 or higher
Animal studies suggest that it may harm the fetus if taken during early gestation
confirm your actual total at checkout before purchasing Compounded tirzepatide price (brand-stated): $125/month on annual plan - same flat-pricing structure
US$ 20.41
US$ 26.58
US$ 22.02
US$ 22.38
US$ 26.96
US$ 22.87
